TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 431.8M
Gross Profit 115.3M 26.71%
Operating Income 29.5M 6.84%
Net Income 20.2M 4.67%

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 537.1M
Shareholders Equity 692.1M
Debt to Equity 0.78

Cash Flow Metrics

Revenue & Profitability Trend

Archit Organosys Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.3B1.1B1.2B1.4B943.4M
Cost of Goods Sold i893.4M894.5M924.8M1.0B709.9M
Gross Profit i362.6M209.1M285.0M362.1M233.4M
Gross Margin % i28.9%18.9%23.6%26.3%24.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-71.4M74.3M65.9M38.5M
Other Operating Expenses i161.9M14.1M6.1M130.7M18.4M
Total Operating Expenses i161.9M85.4M80.4M196.5M56.9M
Operating Income i70.3M12.0M147.3M119.5M77.2M
Operating Margin % i5.6%1.1%12.2%8.7%8.2%
Non-Operating Items
Interest Income i-13.2M3.1M10.7M4.9M
Interest Expense i25.8M25.8M21.6M24.4M31.7M
Other Non-Operating Income-----
Pre-tax Income i75.4M43.2M153.6M114.3M46.8M
Income Tax i24.9M10.5M40.1M31.9M-3.2M
Effective Tax Rate % i33.0%24.2%26.1%28.0%-6.9%
Net Income i50.5M32.8M113.5M82.3M50.1M
Net Margin % i4.0%3.0%9.4%6.0%5.3%
Key Metrics
EBITDA i160.6M86.6M201.4M185.5M118.1M
EPS (Basic) i-₹1.60₹5.53₹4.01₹3.33
EPS (Diluted) i-₹1.60₹5.53₹4.01₹3.33
Basic Shares Outstanding i-20520723205207232052743115020723
Diluted Shares Outstanding i-20520723205207232052743115020723

Income Statement Trend

Archit Organosys Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i681.0K38.2M50.2M53.5M38.1M
Short-term Investments i3.8M4.0M3.6M9.5M9.7M
Accounts Receivable i230.5M222.3M373.6M273.5M250.0M
Inventory i43.0M34.4M33.8M59.4M35.4M
Other Current Assets8.0M13.3M8.3M9.1M6.9M
Total Current Assets i615.0M414.9M479.4M429.3M341.7M
Non-Current Assets
Property, Plant & Equipment i539.7M596.6M504.6M450.5M476.7M
Goodwill i00002.0K
Intangible Assets i----2.0K
Long-term Investments-----
Other Non-Current Assets-10.0K2.0M13.4M1.0K1.6M
Total Non-Current Assets i614.2M667.5M722.3M606.3M533.2M
Total Assets i1.2B1.1B1.2B1.0B874.9M
Liabilities
Current Liabilities
Accounts Payable i217.9M134.6M231.9M135.6M146.1M
Short-term Debt i226.3M181.7M167.7M205.5M183.1M
Current Portion of Long-term Debt-----
Other Current Liabilities5.0M208.0K5.8M2.6M2.1M
Total Current Liabilities i457.0M342.6M419.0M376.0M342.8M
Non-Current Liabilities
Long-term Debt i49.6M82.7M146.3M134.2M124.1M
Deferred Tax Liabilities i28.1M13.2M17.6M3.7M0
Other Non-Current Liabilities--39.0K--
Total Non-Current Liabilities i80.1M98.3M164.9M140.6M126.7M
Total Liabilities i537.1M440.9M584.0M516.6M469.5M
Equity
Common Stock i205.2M205.2M205.2M205.2M150.2M
Retained Earnings i-249.8M225.6M127.5M55.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i692.1M641.5M617.8M518.9M405.4M
Key Metrics
Total Debt i276.0M264.4M314.1M339.7M307.2M
Working Capital i157.9M72.2M60.4M53.2M-1.1M

Balance Sheet Composition

Archit Organosys Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i75.4M43.2M153.6M114.3M46.8M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-3.3M140.2M-66.8M-45.9M-27.4M
Operating Cash Flow i70.4M195.5M103.7M87.7M47.5M
Investing Activities
Capital Expenditures i-3.6M46.7M-116.3M-107.4M-30.2M
Acquisitions i-4.3M810.0K0--
Investment Purchases i-915.0K-29.5M-18.0M-11.0M-3.0M
Investment Sales i-10.9M-00
Investing Cash Flow i-8.8M28.9M-134.3M-118.4M-33.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-5.0K-9.9M-14.4M-10.3M-
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i44.3M11.2M-14.3M31.0M13.8M
Free Cash Flow i180.2M83.0M12.2M-2.2M79.5M
Net Change in Cash i105.9M235.7M-44.8M246.0K28.1M

Cash Flow Trend

Archit Organosys Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 19.00
Price to Book 1.39
Price to Sales 0.73

Profitability Ratios

Profit Margin 4.62%
Operating Margin 7.98%
Return on Equity 7.30%
Return on Assets 4.11%

Financial Health

Current Ratio 1.35
Debt to Equity 39.88
Beta -0.35

Per Share Data

EPS (TTM) ₹2.46
Book Value per Share ₹33.62
Revenue per Share ₹63.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
architorg958.9M19.001.397.30%4.62%39.88
Navin Fluorine 255.9B69.939.4410.99%13.90%55.85
Deepak Nitrite 253.2B41.674.7011.85%7.58%23.36
India Glycols 50.0B20.492.2110.24%6.35%83.85
Styrenix Performance 46.4B20.533.9720.14%7.00%34.02
Gujarat Alkalies 40.4B70.120.67-1.08%-0.82%9.30

Financial data is updated regularly. All figures are in the company's reporting currency.